|Articles|January 27, 2022
Supplements and Featured Publications
- The Underrecognized Burden of Atopic Dermatitis in the United States
The Underrecognized Burden of Atopic Dermatitis in the United States
Advertisement
This publication is sponsored by AbbVie Inc.
This Clinical Brief provides an overview of the complex pathogenesis, heavy burden, and limited diagnostic, staging, and therapeutic options available for more severe atopic dermatitis.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
3
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
4
ICER Draft Flags High Cost of New Hypertension Drug Class
5